About Contact Us Careers

Orthobiologics Market Share

Request Free Sample Copy

Report ID: 773
Published Date: Oct 10, 2024
Report Format: PDF, PPT

Buy Now

Orthobiologics Market Share

Regionally, the global orthobiologics market is studied into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. Amongst these markets, the market in North America region is projected to hold the largest market share by the end of 2037. The growth of the market is ascribed to the rising geriatric population with severe bone diseases and the ongoing development in the healthcare expenditure of the region. As per the data published by the World Bank, it was noticed that the geriatric population in the United States reached 56,545,938 in 2021.

Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:

Orthobiologics Market Size & Share, Growth Trends 2037

Author Credits: Radhika Pawar

Report ID: 773
Published Date: Oct 10, 2024
Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of orthobiologics is evaluated at USD 8.84 billion.

The orthobiologics market size was valued at USD 8.46 billion in 2024 and is expected to exceed USD 17.04 billion by the end of 2037, expanding at over 5.7% CAGR during the forecast period i.e., between 2025-2037. Increasing sales of orthopedic devices and rising cases of osteoporosis across the globe will boost the market growth.

North America industry is poised to hold largest revenue share by 2037, due to rising geriatric population with severe bone diseases and ongoing development in the healthcare expenditure of the region.

The major players in the market include Wright Medical Group N.V., Zimmer Biomet Holdings, Inc., Arthrex, Inc., Medical Device Business Services, Inc., Johnson & Johnson & Services, Inc., RTI Surgical, Inc., MTG Learning Media Pvt. Ltd., and others.

Inquiry Before Buying Request Free Sample